KAKKIS EMIL D

RARE

KAKKIS EMIL D serves as director, officer: President & CEO at Ultragenyx Pharmaceutical Inc. (RARE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$6.63M

Net Position

Net Seller

$6.63M

Companies Traded

RARE

Active Period

Feb 2025 – Mar 2026

2 total trades

Most Recent

Sell RARE

Mar 3, 2026 · $2.48M

KAKKIS EMIL D's Insider Trading at Ultragenyx Pharmaceutical Inc. (RARE)

Buys

0 · $0.00

Sells

2 · $6.63M

Total Shares Bought

Total Shares Sold

207,242

RARE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 3, 2026↗	Sell	108,808	$22.80	$2.48M	658,994
Feb 28, 2025↗	Sell	98,434	$42.20	$4.15M	0

Related Insiders

Karah Herdman Parschauer

officer: EVP and Chief Legal Officer

RARESell · Mar 10, 2026

Howard Horn

officer: Chief Financial Officer

RARESell · Mar 3, 2026

Erik Harris

officer: EVP & Chief Commercial Officer

RARESell · Mar 2, 2026

Theodore Alan Huizenga

officer: SVP, Chief Accounting Officer

RARESell · Mar 2, 2026

Eric Crombez

officer: EVP and Chief Medical Officer

RARESell · Mar 2, 2026

John Richard Pinion

officer: See Remarks

RARESell · Mar 2, 2026

Eric Crombez

EVP and Chief Medical Officer

RARESell · May 5, 2025

Explore More Insider Trading Data

RARE Insider Trading Activity

View all insider trades at Ultragenyx Pharmaceutical Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity